Home The Word Brain Fast Track My Amedeo FAQ About Flying Publisher   

Fast Track

Ear2MemoryFree App | Free PDF | Web
Learning languages on your smartphone
By BSK

Free Abstracts

  Bladder Cancer

  Free Subscription


18.09.2017

1 Biomaterials
1 BJU Int
1 BMC Urol
1 Br J Cancer
1 Cancer
1 Clin Genitourin Cancer
1 Cochrane Database Syst Rev
1 Eur Urol Focus
1 Hum Pathol
1 Int J Mol Cell Med
1 Int J Surg Pathol
1 J Clin Endocrinol Metab
1 J Endourol
1 J Pediatr Hematol Oncol
1 Mater Sci Eng C Mater Biol Appl
1 Medicine (Baltimore)
4 Methods Mol Biol
2 Nat Rev Urol
2 Neoplasma
1 Oncol Res
2 Oncotarget
1 PLoS One
1 Postepy Hig Med Dosw (Online)
1 Urol Oncol
1 Virchows Arch
1 World J Surg Oncol


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Biomaterials

  1. RINGUETTE GOULET C, Bernard G, Chabaud S, Couture A, et al
    Tissue-engineered human 3D model of bladder cancer for invasion study and drug discovery.
    Biomaterials. 2017;145:233-241.
    PubMed     Text format     Abstract available


    BJU Int

  2. VETTERLEIN MW, Gild P, Kluth LA, Seisen T, et al
    Perioperative Allogeneic Blood Transfusion Does Not Adversely Impact Oncological Outcomes After Radical Cystectomy for Urinary Bladder Cancer - a Propensity Score-weighted European Multicenter Study.
    BJU Int. 2017 Sep 14. doi: 10.1111/bju.14012.
    PubMed     Text format     Abstract available


    BMC Urol

  3. ZHANG Q, Zhang S, Zhang S, Wang W, et al
    Transperineal cryotherapy for unresectable muscle invasive bladder cancer: preliminary experience with 7 male patients.
    BMC Urol. 2017;17:81.
    PubMed     Text format     Abstract available


    Br J Cancer

  4. KOSHIARIS C, Aveyard P, Oke J, Ryan R, et al
    Smoking cessation and survival in lung, upper aero-digestive tract and bladder cancer: cohort study.
    Br J Cancer. 2017 Sep 12. doi: 10.1038/bjc.2017.
    PubMed     Text format     Abstract available


    Cancer

  5. PIATON E, Advenier AS, Carre C, Decaussin-Petrucci M, et al
    p16/Ki-67 dual labeling and urinary cytology results according to the New Paris System for Reporting Urinary Cytology: Impact of extended follow-up.
    Cancer. 2017;125:552-562.
    PubMed     Text format     Abstract available


    Clin Genitourin Cancer

  6. VETTERLEIN MW, Seisen T, Leow JJ, Preston MA, et al
    Effect of Nonurothelial Histologic Variants on the Outcomes of Radical Cystectomy for Nonmetastatic Muscle-invasive Urinary Bladder Cancer.
    Clin Genitourin Cancer. 2017 Aug 24. pii: S1558-7673(17)30248.
    PubMed     Text format     Abstract available


    Cochrane Database Syst Rev

  7. JUNG JH, Gudeloglu A, Kiziloz H, Kuntz GM, et al
    Intravesical electromotive drug administration for non-muscle invasive bladder cancer.
    Cochrane Database Syst Rev. 2017;9:CD011864.
    PubMed     Text format     Abstract available


    Eur Urol Focus

  8. UHLIG A, Strauss A, Seif Amir Hosseini A, Lotz J, et al
    Gender-specific Differences in Recurrence of Non-muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis.
    Eur Urol Focus. 2017 Sep 6. pii: S2405-4569(17)30199.
    PubMed     Text format     Abstract available


    Hum Pathol

  9. INOUE S, Mizushima T, Fujita K, Meliti A, et al
    GATA3 immunohistochemistry in urothelial carcinoma of the upper urinary tract as a urothelial marker and a prognosticator.
    Hum Pathol. 2017;64:83-90.
    PubMed     Text format     Abstract available


    Int J Mol Cell Med

  10. GANJI SM, Saidijam M, Amini R, Mousavi-Bahar SH, et al
    Evaluation of MicroRNA-99a and MicroRNA-205 Expression Levels in Bladder Cancer.
    Int J Mol Cell Med. 2017;6:87-95.
    PubMed     Text format     Abstract available


    Int J Surg Pathol

  11. GORDETSKY J, Collingwood R, Lai WS, Del Carmen Rodriquez Pena M, et al
    Second Opinion Expert Pathology Review in Bladder Cancer: Implications for Patient Care.
    Int J Surg Pathol. 2017 Sep 1:1066896917730903. doi: 10.1177/1066896917730903.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  12. SWERDLOW AJ, Cooke R, Beckers D, Borgstrom B, et al
    Cancer Risks in Patients Treated With Growth Hormone in Childhood: The SAGhE European Cohort Study.
    J Clin Endocrinol Metab. 2017;102:1661-1672.
    PubMed     Text format     Abstract available


    J Endourol

  13. TAN WS, Lamb BW, Khetrapal P, Tan MY, et al
    Blood Transfusion Requirement and Not Preoperative Anemia Are Associated with Perioperative Complications Following Intracorporeal Robot-Assisted Radical Cystectomy.
    J Endourol. 2017;31:141-148.
    PubMed     Text format     Abstract available


    J Pediatr Hematol Oncol

  14. SUMA TL, Ramanathan S, Padma M, Appaji L, et al
    A Case of Urachal Yolk Sac Tumor With Spontaneous Rupture in a Child.
    J Pediatr Hematol Oncol. 2017;39:e82-e84.
    PubMed     Text format     Abstract available


    Mater Sci Eng C Mater Biol Appl

  15. NI W, Li M, Cui J, Xing Z, et al
    808nm light triggered black TiO2 nanoparticles for killing of bladder cancer cells.
    Mater Sci Eng C Mater Biol Appl. 2017;81:252-260.
    PubMed     Text format     Abstract available


    Medicine (Baltimore)

  16. LIANG L, Zhou N, Xu H, Liu D, et al
    Urachal mucinous adenocarcinoma with pseudomyxoma peritonei: A case report.
    Medicine (Baltimore). 2017;96:e7548.
    PubMed     Text format     Abstract available


    Methods Mol Biol

  17. TOMMASI S, Besaratinia A
    A Versatile Assay for Detection of Aberrant DNA Methylation in Bladder Cancer.
    Methods Mol Biol. 2018;1655:29-41.
    PubMed     Text format     Abstract available

  18. OLIVEIRA PA, Vasconcelos-Nobrega C, Gil da Costa RM, Arantes-Rodrigues R, et al
    The N-butyl-N-4-hydroxybutyl Nitrosamine Mouse Urinary Bladder Cancer Model.
    Methods Mol Biol. 2018;1655:155-167.
    PubMed     Text format     Abstract available

  19. BERNARDO C, Santos LL
    Patient-Derived Bladder Cancer Xenografts.
    Methods Mol Biol. 2018;1655:169-175.
    PubMed     Text format     Abstract available

  20. SATHE A, Nawroth R
    Targeting the PI3K/AKT/mTOR Pathway in Bladder Cancer.
    Methods Mol Biol. 2018;1655:335-350.
    PubMed     Text format     Abstract available


    Nat Rev Urol

  21. MOSCHINI M, D'Andrea D, Korn S, Irmak Y, et al
    Characteristics and clinical significance of histological variants of bladder cancer.
    Nat Rev Urol. 2017 Sep 12. doi: 10.1038/nrurol.2017.
    PubMed     Text format     Abstract available

  22. SIDAWAY P
    Bladder cancer: IFNalpha-2b gene transfer: a new approach for BCG-resistant disease.
    Nat Rev Urol. 2017 Sep 12. doi: 10.1038/nrurol.2017.
    PubMed     Text format    


    Neoplasma

  23. YANG L, Xue Y, Liu J, Zhuang J, et al
    Long noncoding RNA ASAP1-IT1 promotes cancer stemness and predicts a poor prognosis in patients with bladder cancer.
    Neoplasma. 2017 Sep 12. doi: 10.4149/neo_2017.
    PubMed     Text format     Abstract available

  24. LIANG Z, Zhang Q, Wang C, Shi F, et al
    Hyaluronic acid/ Hyaluronidase as biomarkers for bladder cancer: a diagnostic meta-analysis.
    Neoplasma. 2017 Sep 12. doi: 10.4149/neo_2017.
    PubMed     Text format     Abstract available


    Oncol Res

  25. SHEN J, Zhang J, Xiao M, Yang J, et al
    MiR-203 Suppresses Bladder Cancer Cell Growth and Targets the Twist1.
    Oncol Res. 2017 Sep 6. doi: 10.3727/096504017X15041934685237.
    PubMed     Text format     Abstract available


    Oncotarget

  26. SEVERINO PF, Silva M, Carrascal M, Malagolini N, et al
    Expression of sialyl-Tn sugar antigen in bladder cancer cells affects response to Bacillus Calmette Guerin (BCG) and to oxidative damage.
    Oncotarget. 2017;8:54506-54517.
    PubMed     Text format     Abstract available

  27. LIU Q, Liao B, Tian Y, Chen Y, et al
    Total fluid consumption and risk of bladder cancer: a meta-analysis with updated data.
    Oncotarget. 2017;8:55467-55477.
    PubMed     Text format     Abstract available


    PLoS One

  28. HUANG P, Lan M, Peng AF, Yu QF, et al
    Serum calcium, alkaline phosphotase and hemoglobin as risk factors for bone metastases in bladder cancer.
    PLoS One. 2017;12:e0183835.
    PubMed     Text format     Abstract available


    Postepy Hig Med Dosw (Online)

  29. SZYMANSKA B, Dlugosz A
    The role of the BLCA-4 nuclear matrix protein in bladder cancer.
    Postepy Hig Med Dosw (Online). 2017;71:681-689.
    PubMed     Text format     Abstract available


    Urol Oncol

  30. MOSCHINI M, Shariat SF, Abufaraj M, Foerster B, et al
    Predicting local failure after radical cystectomy in patients with bladder cancer: Implications for the selection of candidates at adjuvant radiation therapy.
    Urol Oncol. 2017 Sep 5. pii: S1078-1439(17)30423.
    PubMed     Text format     Abstract available


    Virchows Arch

  31. FURUDOI A, Varinot J, Phe V, Roupret M, et al
    Urothelial carcinoma in first histological diagnosis of patients over 80 years has distinctive histological features: a retrospective single-institution study of 185 patients.
    Virchows Arch. 2017;470:561-565.
    PubMed     Text format     Abstract available


    World J Surg Oncol

  32. IMAOKA Y, Kuranishi F, Miyazaki T, Yasuda H, et al
    Long-lasting complete response status of advanced stage IV gall bladder cancer and colon cancer after combined treatment including autologous formalin-fixed tumor vaccine: two case reports.
    World J Surg Oncol. 2017;15:170.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Bladder Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: